RxDoctor Payments Data

Amy Hull

Adult Health · Pottstown, PANPI 1710943063

Payments from drug & device makers

$4,547in general payments, 2019–2025

Across 241 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$957
  • Novo Nordisk$391
  • AstraZeneca$351
  • Pfizer$306
  • GSK$303
  • Lilly USA, LLC$283
  • plus $2K from 36 others

What the payments were for

  • Food & beverage$4,48599%
  • Education$621%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,547 in reported general payments places this provider in the 90th percentile of 899 adult health providers in Pennsylvania.

See all adult health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$100,892
Medicare patients
363
Services billed
1,493

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban94$98,553
OzempicSemaglutide99$96,081
JardianceEmpagliflozin61$81,087
Nurtec OdtRimegepant Sulfate31$64,584
JanuviaSitagliptin Phosphate50$50,787
TrulicityDulaglutide34$44,724
MounjaroTirzepatide25$29,677
JanumetSitagliptin Phos/Metformin Hcl17$24,558
Soliqua 100-33Insulin Glargine/Lixisenatide19$22,224
XareltoRivaroxaban15$19,089
FarxigaDapagliflozin Propanediol15$18,318
Breo ElliptaFluticasone/Vilanterol31$14,602
MyrbetriqMirabegron24$14,199
LinzessLinaclotide17$10,177
Effexor XrVenlafaxine Hcl30$6,696

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt, Effexor Xr$306$169,833155 claims
Novo NordiskOzempic$391$96,08199 claims
Boehringer IngelheimJardiance, Synjardy$123$87,47273 claims
MerckJanuvia, Janumet$101$75,34567 claims
Lilly USA, LLCTrulicity, Mounjaro$283$74,40259 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$64$22,22419 claims
Johnson & JohnsonXarelto$80$19,08915 claims
AstraZenecaFarxiga$351$18,31815 claims
GSKBreo Ellipta$303$14,60231 claims
Astellas Pharma US IncMyrbetriq$155$14,19924 claims
AbbVieLinzess, Synthroid$957$12,62047 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 899 adult health providers in Pennsylvania.

Other adult health in Pottstown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →